Multiple Myeloma Cancer and An Overview of the Disease

Authors : Mehek Isharani

Volume/Issue : Volume 8 - 2023, Issue 9 - September

Google Scholar :

Scribd :


Multiple Myeloma, a rare and complex form of blood cancer, presents significant challenges in both diagnosis and treatment. This malignancy arises from malfunctioning plasma cells and is characterized by excessive monoclonal immunoglobulin production, leading to damage to vital organs. Despite advances in cancer research and substantial funding, the disease remains difficult to detect in its early stages. Current treatment options, including chemotherapy, steroids, and stem cell transplantation, are associated with notable side effects. However, the emergence of CRISPR-based genome editing technology offers promising avenues for personalized treatment and novel research approaches, though concerns about off-target effects have slowed clinical adoption. As the battle against Multiple Myeloma continues, CRISPR represents a beacon of hope for more effective and precise interventions in the future. This study aims to explore the disease, the effect of the current treatments, and the possible impact CRISPR may have on finding a cure for the disease and changing the course of treatment.


Paper Submission Last Date
31 - December - 2023

Paper Review Notification
In 1-2 Days

Paper Publishing
In 2-3 Days

Video Explanation for Published paper

Never miss an update from Papermashup

Get notified about the latest tutorials and downloads.

Subscribe by Email

Get alerts directly into your inbox after each post and stay updated.

Subscribe by RSS

Add our RSS to your feedreader to get regular updates from us.